Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

about

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Item

http://www.wikidata.org/entity/Q50133191

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@en

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@nl

type

Item

label

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@en

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@nl

prefLabel

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@en

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@nl

P1476

Thoracic Complications of Prec ...... in the New Era of Cancer Care.

@en

P2093

Hiroto Hatabu

http://www.w3.org/2001/XMLSchema#string

Lynette M Sholl

http://www.w3.org/2001/XMLSchema#string

Mizuki Nishino

http://www.w3.org/2001/XMLSchema#string

Nikhil H Ramaiya

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.

The blockade of immune checkpoints in cancer immunotherapy

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Diagnosis and management of drug-associated interstitial lung disease

P304

1371-1387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RG.2017170015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28898185

http://www.w3.org/2001/XMLSchema#string

P932

5621730

http://www.w3.org/2001/XMLSchema#string